Progressive Multifocal Leukoencephalopathy Journals
Progressive multifocal leukoencephalopathy (PML) could be a sickness of the substantia alba of the brain, caused by a deadly disease infection that targets
cells that create myelin--the material that insulates nerve
cells (neurons). Polyomavirus JC (often referred to as JC virus) is carried by a majority of individuals and is harmless except among those with lowered immune defenses. The sickness is rare and happens in patients undergoing chronic corticoid or immunological disorder medical aid for surgical process, or people with
cancer (such as Hodgkin’s sickness or lymphoma). people with response conditions like disseminated sclerosis, atrophic arthritis, and general LE -- a number of whom ar treated with biological therapies that enable JC virus reactivation -- ar in danger for PML still. PML is most typical among people with HIV-1
infection / nonheritable immune deficiency
syndrome (AIDS). Studies estimate that before effective antiretroviral medical aid, as several as five p.c of persons infected with HIV-1 eventually develop PML that's associate degree AIDS-defining health problem. However, current HIV medical aid victimization antiretroviral medicine (ART), that effectively restores system operate, permits as several as half all HIV-PML patients to survive, though they will generally have associate degree inflammatory reaction within the regions of the brain suffering from PML. The symptoms of PML ar various, since they're associated with the situation and quantity of injury within the brain, and will evolve over the course of many weeks to months the foremost outstanding symptoms ar clumsiness; progressive weakness; and visual, speech, and generally temperament changes. The progression of deficits results in critical incapacity and (frequently) death.
High Impact List of Articles
-
Targeted cancer therapy
Xiaoguang Liu*, Chao Ma & Lufang Zhou
Editorial: Pharmaceutical Bioprocessing
-
Targeted cancer therapy
Xiaoguang Liu*, Chao Ma & Lufang Zhou
Editorial: Pharmaceutical Bioprocessing
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
Role and timing of coronary intervention in non-ST-elevation myocardial infarction
KD Mahmoud & DR Holmes
Review Article: Interventional Cardiology
-
Role and timing of coronary intervention in non-ST-elevation myocardial infarction
KD Mahmoud & DR Holmes
Review Article: Interventional Cardiology
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Primary sclerosing cholangitis clinical trials: mission impossible.... for now
Bret Lashner
Editorial: Clinical Investigation
-
Comparative efficacy of daily versus alternate-day dosing of atorvastatin in Type 2 diabetic patients
Molouk Hadjibabaie, Sanaz Vosough-Ghanbari, Mania Radfar, Kheirollah Gholami, Seyed Hamid Khoei, Manoochehr Nakhjavani, Manijeh Ahani and Mohammad Abdollahi
Research Article: Clinical Practice
-
Comparative efficacy of daily versus alternate-day dosing of atorvastatin in Type 2 diabetic patients
Molouk Hadjibabaie, Sanaz Vosough-Ghanbari, Mania Radfar, Kheirollah Gholami, Seyed Hamid Khoei, Manoochehr Nakhjavani, Manijeh Ahani and Mohammad Abdollahi
Research Article: Clinical Practice
-
Atomoxetine in the treatment of children, adolescents and adults with attention deficit hyperactivity disorder
Atilla Turgay
Drug Evaluation: Clinical Practice
-
Atomoxetine in the treatment of children, adolescents and adults with attention deficit hyperactivity disorder
Atilla Turgay
Drug Evaluation: Clinical Practice
Relevant Topics in Clinical